US$ 26.65
how much is direct meds tirzepatide Eli Lilly's Popular Weight Loss Drug, Zepbound, Getting a Price Cut Direct Meds
Description
Novo Nordisk, AstraZeneca, Eli lilly and Company, Sanofi and Pfizer are the major companies operating in this market.

In 2023, the FDA will likely approve Eli Lilly's diabetes drug tirzepatide for weight loss but there's little indication insurers will widely cover the medication.
The tools are coming

Weight-loss clinics and medical wellness centers
